Harvest Fund Management »

Halozyme Therapeutics shares owned by Harvest Fund Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Harvest Fund Management from 13F filings

Historical chart of Harvest Fund Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Harvest Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Harvest Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $499k 7.7k 64.60
2025-12-31 $329k 4.9k 67.23
2025-09-30 $359k 4.9k 73.36
2025-06-30 $0 5 0.00
2025-03-31 $89k 1.4k 63.94
2024-09-30 $163k 2.8k 57.21
2022-12-31 $57k 1.0k 56.89
2022-06-30 $87k 2.0k 44.10
2021-09-30 $19k 473 40.17
2021-06-30 $38k 839 45.29
2021-03-31 $69k 1.7k 41.14
2020-12-31 $71k 1.7k 42.34
2020-09-30 $44k 1.7k 26.24